The use of intravenously administered immunoglobulins in the prevention of severe infection in very low birth weight neonates.
In a randomized prospective study in 116 selected neonates with very low birth weight, the effect of standard doses of intravenously administered immunoglobulins (IVIG) on the occurrence of severe infections was studied. No difference in infection rate or severity of infection could be observed between the treated neonates and the control group. The lack of effect could not be explained by an insufficient increase in the IgG serum levels, or inversely, by high immunosuppressive IgG levels. It is concluded that in very low birth weight neonates the administration of IVIG, under the conditions used in this investigation, does not protect against severe infection.
van Overmeire
B
B
Department of Pediatrics, University Hospital of Antwerp, Belgium.
Bleyaert
S
S
van Reempts
P J
PJ
van Acker
K J
KJ
D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D015994:Incidence; D007230:Infant, Low Birth Weight / Q000097:blood; D007231:Infant, Newborn; D017053:Infection Control / Q000379:methods*; D007239:Infections / Q000453:epidemiology / Q000382:microbiology; D008297:Male; D011446:Prospective Studies; D012016:Reference Values; D017211:Treatment Failure
D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous